Persistence Market Research Blog

Posts tagged ‘Human Insulin Market’

Human Insulin Market is expected to grow at a CAGR of 12.4% from 2014 to 2020

According to a new market report published by Persistence Market Research “Global Market Study on Human Insulin: Asia Pacific to Witness fastest Growth by 2020,” the global human insulin market was valued at USD 24,332.6 million in 2014 and was expected to grow at a CAGR of 12.4% from 2014 to 2020, to reach an estimated value of USD 49,197.3 million in 2020.

Browse the full Global Market Study on Human Insulin: Asia Pacific to Witness fastest Growth by 2020 report at http://www.persistencemarketresearch.com/market-research/human-insulin-market.asp

Globally, the human insulin market is witnessing significant growth due to increasing prevalence of diabetes and increasing awareness among people about diabetes care. In addition, technological advancements in insulin delivery devices and increasing prevalence of lifestyle related disorders such as obesity are also driving the growth of the market. However, uneven pricing and limited access to human insulin in emerging countries such as Brazil, India, and China are inhibiting the growth of the human insulin market. In addition, strict regulatory requirements for drug approval are also restraining the growth of the market. The global human insulin market was anticipated to grow from an estimated USD 24,332.6 million in 2014 to USD 49,197.3 million in 2020 at a CAGR of 12.4% during the forecast period.

In North America, increasing prevalence of diabetes with growing age and availability of advanced human insulin infusion devices are driving the use of human insulin in the market.

In addition, increasing prevalence of lifestyle associated disorders such as obesity is also boosting the growth of the human insulin market in this region. For instance, according to the Centers for Diseases Control and Prevention (CDC), a U.S.-based national public health institute, over one-third children and adolescents were obese in 2012 in the U.S.

In Europe, the human insulin market is driven by rising aging population and increasing prevalence of diabetes. In addition, in Germany the market is evolving due to rising prevalence of diabetes and increasing awareness among people about diabetes care. However, in Asia-Pacific the growth for human insulin is much higher than developed countries due to increasing prevalence of diabetes and increasing government initiatives for improving healthcare.

Novo Nordisk A/S, Eli Lilly and Company, Sanofi, Biocon, Tonghua Dongbao Pharmaceutical Co., Ltd., Adocia, Merck & Co., Inc., Pfizer, Inc., Wockhardt, Julphar, Bristol-Myers Squibb Company, GlaxoSmithKline Plc and Oramed Pharmaceuticals, Inc. are some of the major players in human insulin market.

The human insulin market is segmented as follows:

Human insulin market, by type

Traditional human insulin

Modern human insulin

Traditional human insulin market, by type

Short acting human insulin

Intermediate acting human insulin

Premixed human insulin

Modern human insulin market, by type

Rapid-acting human insulin

Long-acting human insulin

Premixed human insulin

Human insulin market, by disease

Type 1 diabetes

Type 2 diabetes

Traditional human insulin market, by brand

Humulin

Insuman

Others

Modern human insulin market, by brand

Lantus

Novolog

Humalog

Levemir

Novomix

Apidra

Others

Human insulin market, by geography

North America

The U.S.

Canada

Europe

Germany

France

The U.K.

Asia-Pacific

Japan

China

India

Rest of the World (RoW)

Human Insulin Market – Global Industry Analysis and Forecast to 2020

Insulin is a naturally occurring hormone that maintains blood sugar levels in the body. Insulin also helps in the proper functioning of all cellular and physiological activities. Insulin is secreted by pancreas. The improper functioning of pancreas leads to diabetes. Diabetes is a disease characterized by high blood sugar levels. People with diabetes are prescribed with insulin to maintain the sugar level in the blood. There are various types of insulin used to treat diabetes such as short acting insulin, rapid acting insulin, intermediate acting insulin and long acting insulin. Insulin is delivered with the help of syringe, insulin pump and injection pen.

Buy full report: http://www.persistencemarketresearch.com/market-research/human-insulin-market.asp

North America dominates the global market for human insulin due to large number of aging population and increasing healthcare cost. Asia is expected to show high growth rates in the next five years in global human insulin market. China and India are expected to be the fastest growing human insulin markets in Asia-Pacific region. Some of the key driving forces for human insulin market in emerging countries are high prevalence rate of insulin and low price of human insulin. 

(more…)

Tag Cloud